Minerva Neurosciences | NERV - Ebitda





Ebitda Alterar Data
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Adma Biologics USD 61.07M 12.52M 2026-03
ALKERMES USD 139.22M 58.96M 2026-06
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
AstraZeneca USD 5.16B 510M 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Cipla INR 14.03B 4.48B 2026-06
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -9.02M 1.12M 2026-03
CSL USD 3.13B 1.17B 2025-12
Eli Lilly USD 10.29B 1.86B 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
J&J USD 8.27B 1.08B 2026-03
Merck USD -1.54B 7.84B 2026-03
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 6.01B 18M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Takeda JPY 364.46B 214.21B 2026-06
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12